Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. [electronic resource]
Producer: 20070216Description: 643-7 p. digitalISSN:- 1476-4687
- Animals
- Benzamides -- pharmacology
- Benzoxazines
- Cannabinoid Receptor Modulators -- metabolism
- Carbamates -- pharmacology
- Disease Models, Animal
- Dopamine -- deficiency
- Dopamine D2 Receptor Antagonists
- Endocannabinoids
- Excitatory Postsynaptic Potentials -- drug effects
- In Vitro Techniques
- Long-Term Synaptic Depression -- drug effects
- Mice
- Mice, Transgenic
- Morpholines -- pharmacology
- Naphthalenes -- pharmacology
- Neostriatum -- cytology
- Neuronal Plasticity -- physiology
- Oxidopamine -- pharmacology
- Parkinson Disease -- metabolism
- Piperidines -- pharmacology
- Psychomotor Performance -- physiology
- Pyrazoles -- pharmacology
- Receptor, Cannabinoid, CB1 -- metabolism
- Receptors, Dopamine D2 -- agonists
- Receptors, N-Methyl-D-Aspartate -- metabolism
- Reserpine -- pharmacology
- Synapses -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.